Both inflammatory response and IFN-γ response pathways were significantly enriched in Aβ-mutant tumors (Supplemental Figure 5B), suggesting these patients have a heightened tumor inflammation signature and may benefit from immunotherapy. This evidence concerns the gene IFNG and neoplasm.